| 000 | 01604 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515042551.0 | ||
| 264 | 0 | _c20061204 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a0365-6233 | ||
| 024 | 7 |
_a10.1002/ardp.200600061 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEl-Hawash, Soad A M | |
| 245 | 0 | 0 |
_aSynthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities. _h[electronic resource] |
| 260 |
_bArchiv der Pharmazie _cOct 2006 |
||
| 300 |
_a564-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Infective Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCandida albicans _xdrug effects |
| 650 | 0 | 4 |
_aCefotaxime _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDimethylformamide _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aNystatin _xpharmacology |
| 650 | 0 | 4 |
_aQuinoxalines _xchemical synthesis |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTriazoles _xchemical synthesis |
| 700 | 1 | _aHabib, Nargues S | |
| 700 | 1 | _aKassem, Mervat A | |
| 773 | 0 |
_tArchiv der Pharmazie _gvol. 339 _gno. 10 _gp. 564-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ardp.200600061 _zAvailable from publisher's website |
| 999 |
_c16587022 _d16587022 |
||